Medical Properties Trust, Inc. (NYSE:MPW) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC decreased its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 25.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 108,139 shares of the real estate investment trust’s stock after selling 36,025 shares during the quarter. Corient Private Wealth LLC’s holdings in Medical Properties Trust were worth $427,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Allworth Financial LP grew its holdings in shares of Medical Properties Trust by 230.4% in the fourth quarter. Allworth Financial LP now owns 6,082 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 4,241 shares during the period. Verus Capital Partners LLC acquired a new position in Medical Properties Trust in the 4th quarter valued at about $40,000. RFG Advisory LLC purchased a new stake in shares of Medical Properties Trust in the 4th quarter valued at approximately $40,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Medical Properties Trust during the 3rd quarter worth approximately $61,000. Finally, Townsquare Capital LLC acquired a new position in Medical Properties Trust in the third quarter valued at approximately $62,000. 71.79% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have commented on MPW. Royal Bank of Canada lifted their target price on Medical Properties Trust from $4.00 to $5.00 and gave the company a “sector perform” rating in a research report on Monday, March 10th. Truist Financial reduced their price objective on shares of Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating on the stock in a report on Thursday, December 19th. Mizuho reduced their price target on shares of Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Thursday, December 5th. BNP Paribas raised shares of Medical Properties Trust from a “neutral” rating to an “outperform” rating and increased their price objective for the stock from $5.00 to $9.00 in a research report on Wednesday, March 12th. Finally, StockNews.com raised Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Medical Properties Trust has a consensus rating of “Hold” and a consensus price target of $5.64.

Medical Properties Trust Stock Performance

Shares of MPW stock opened at $6.04 on Friday. Medical Properties Trust, Inc. has a 52 week low of $3.51 and a 52 week high of $6.55. The firm has a 50 day moving average of $5.25 and a two-hundred day moving average of $4.84. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. The stock has a market capitalization of $3.62 billion, a PE ratio of -1.43, a P/E/G ratio of 1.01 and a beta of 1.32.

Medical Properties Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 10th will be paid a dividend of $0.08 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $0.32 annualized dividend and a yield of 5.30%. Medical Properties Trust’s payout ratio is -8.42%.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.